Get the latest news on Kiromic BioPharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on KRBPQ performance

Latest Kiromic BioPharma Stock News | OTC:KRBPQ | Benzinga

Kiromic BioPharma Inc is a biotechnology company. It is an artificial intelligence (AI) driven, end-to-end allogeneic cell therapy company, currently developing the multi-indication allogeneic T cell therapy that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The company is a gene-editing which utilizes artificial intelligence and a proprietary neural network platform with a therapeutic focus on immuno-oncology.

KIROMIC BIOPHARMA INC by Kiromic BioPharma, Inc.

Comments

Kiromic BioPharma Stock News

News

Latest Kiromic BioPharma Stock News | OTC:KRBPQ | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga